Company: NCEL
Filing Date: 2025-11-06
Form Type: POS AM
Source: 0001213900-25-106799
Chunk: 77

Company: NewcelX Ltd.
Filing Date: 2025-11-06
Form: POS AM
Chunk 77
---
     |   1,430 |         |     |          903 |   |

____________ (*)Less than $1. The accompanying notes are an integral part of the interim financial statements.

| August 31, 2025                              |     |                                                     |     |            |     |                       |
|:---------------------------------------------|:----|:----------------------------------------------------|:----|:-----------|:----|:----------------------|
| Date of approval of the financial statements |     | Ronen Twito CEO and Executive Chairman of the Board |     | Liora Oren 
 Director   |     | Uri Ben Or            
 Chief Finance Officer |

Annex B-2

KADIMASTEM LTD.
STATEMENTS OF PROFIT OR LOSS AND OTHER COMPREHENSIVE LOSS

| 2025                                                                                                                   |     | Six months ended 
          June 30 | 2024 |     |       |         |     |   Year ended 
 December 31, 
         2024 |   |
|:-----------------------------------------------------------------------------------------------------------------------|:----|-----------------:|:-----|:----|------:|:--------|:----|-------------:|:--|
| Unaudited                                                                                                              |     |                  |      |     |       | Audited |     |              |   |
| USD in thousands (except per share data)                                                                               |     |                  |      |     |       |         |     |              |   |
| Research and development expenses, net                                                                                 |     |              576 |      |     |   410 |         |     |          992 |   |
| General and administrative expenses                                                                                    |     |              685 |      |     |   376 |         |     |          793 |   |
| Other expenses (expenses for merger with NLS)                                                                          |     |              101 |      |     |     — |         |     |          269 |   |
| Operating loss                                                                                                         |     |            1,362 |      |     |   786 |         |     |        2,054 |   |
| Finance income                                                                                                         |     |              (54 | )    |     |  (196 | )       |     |           (6 | ) |
| Finance expenses related to derivative of conversion component of convertible loan and warrants and shareholder loans. |     |            9,923 |      |     |   548 |         |     |        5,044 |   |
| Other finance expenses